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ABSTRACT Prosthetic joint failure is mainly caused by infection, aseptic failure (AF),
and mechanical problems. Infection detection has been improved with modified cul-
ture methods and molecular diagnostics. However, comparisons between modi-
fied and conventional microbiology methods are difficult due to variations in speci-
men sampling. In this prospective, multidisciplinary study of hip or knee prosthetic
failures, we assessed the contributions of different specimen types, extended culture
incubations, and 16S rRNA sequencing for diagnosing prosthetic joint infections
(PJI). Project specimens included joint fluid (JF), bone biopsy specimens (BB), soft-
tissue biopsy specimens (STB), and swabs (SW) from the prosthesis, collected in situ,
and sonication fluid collected from prosthetic components (PC). Specimens were cul-
tured for 6 (conventional) or 14 days, and 16S rRNA sequencing was performed at
study completion. Of the 156 patients enrolled, 111 underwent 114 surgical revi-
sions (cases) due to indications of either PJI (n  43) or AF (n  71). Conventional
tissue biopsy cultures confirmed PJI in 28/43 (65%) cases and refuted AF in 3/71
(4%) cases; one case was not evaluable. Based on these results, minor diagnostic ad-
justments were made. Fourteen-day cultures of JF, STB, and PC specimens confirmed
PJI in 39/42 (93%) cases, and 16S rRNA sequencing confirmed PJI in 33/42 (83%)
cases. One PJI case was confirmed with 16S rRNA sequencing alone and five with
cultures of project specimens alone. These findings indicated that JF, STB, and PC
specimen cultures qualified as an optimal diagnostic set. The contribution of se-
quencing to diagnosis of PJI may depend on patient selection; this hypothesis re-
quires further investigation.
KEYWORDS joint prosthesis, infection, biofilm, diagnosis (microbiology), RNA,
ribosomal, 16S, 16S RNA, biofilms, diagnostics, joint infections, prospective clinical
study, prosthesis infections
The issue of which specimens would be optimal to acquire during revision surgeryfor patients suspected of prosthetic joint infection (PJI) has been repeatedly con-
tested. In Scandinavian countries, since the early 1980s, multiple periprosthetic soft-
tissue biopsy specimens (STB) have been used extensively (1), and these have become
standard for diagnosing PJIs. However, the number of culture-positive biopsy speci-
mens needed to diagnose a PJI has varied (2). In 1998, a prospective study by Atkins
et al. (3) reported a high positive predictive value for two or more culture-positive
biopsy specimens, and this finding was later confirmed in another study (4). In the late
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1990s, biofilms were identified on prosthetic elements from infected hip joints (5). This
finding led to new diagnostic options, including sonicating the removed prosthesis
and culturing the sonication fluid (6, 7).
Two recently published sets of European and American guidelines recommended
collecting two to six intraoperative tissue biopsy specimens during surgery and sub-
mitting them to culture. Infections would be indicated when two or more biopsy
specimens were positive for the same microorganism. As an adjunct, an examination of
prosthetic components (PCs) was recommended for diagnostic work-ups (8, 9).
Currently, culture assays remain the standard for ascertaining a PJI diagnosis;
however, since the late 1990s, molecular diagnostics have gained ground, particularly
methods that target 16S rRNA with either multiplex PCR or sequencing strategies
(10–12). Newer studies have investigated the diagnostic accuracy of combining mo-
lecular methods and specimen types, but different studies have reported varying
sensitivity (13, 14). A growing number of in-house molecular tests have emphasized the
need for independent studies of clinical utility (15, 16). In addition, although several
specimen types have been studied extensively (6, 14, 17–23), only a few studies had a
prospective design that implemented criteria for patient selection, sampling of multiple
specimen types, and optimized culture methods (24).
Recently, a prospective Danish study enrolled patients with a painful or dysfunc-
tional hip or knee prosthetic joint. This study provided an opportunity for standardized
sampling of different specimen types and application of both culturing and 16S rRNA
sequencing for diagnosing PJI. The primary goal was to define an optimal specimen set
for diagnosing PJIs; the secondary goal was to define the utility of 16S rRNA sequencing
in microbial diagnostics.
(Preliminary results were presented at the European Congress of Clinical Microbiol-
ogy and Infectious Diseases [ECCMID] in 2014 [25] and 2015 [26] and at the 33rd Annual
Meeting of the European Bone & Joint Infection Society [EBJIS] in 2014 [27]).
MATERIALS AND METHODS
Diagnostic algorithm. The diagnostic algorithm differed from the standard care mainly in two
aspects. First, the algorithm included an option for radionuclide imaging, and when a hot spot was
revealed, it was followed by a biopsy procedure (27). Second, the algorithm included an extensive
work-up of the specimens obtained during surgical revision (details given below). Deviations from
the algorithm were accepted based on preferences of the patient or surgeon. For example, a joint
puncture was not recommended as a primary diagnostic step, because it might interfere with radionu-
clide imaging; however, it was permissible when deemed necessary by the surgeon. Radionuclide
imaging was performed in a subset of patients, and images were evaluated by a multidisciplinary
specialist team. However, radionuclide imaging did not provide independent diagnostic evidence, and
the images were not considered in this study.
Specimens. Joint fluid was collected with a separate diagnostic procedure at the surgeon’s discretion
(see above). Also, prior to any joint capsule incision during revision surgery, sampling was obligatory. The
sets of five STBs (5-STB) were collected from a single periprosthetic site, according to local guidelines and
as described previously by Kamme and Lindberg (1). The project specimens comprised three peripros-
thetic STBs, three swabs (SWs) (ESwab, Copan, Italy), three periprosthetic bone biopsy specimens (BBs),
and any removed PCs. The STBs were acquired from a periprosthetic site (preferably with signs of
infection), the prosthesis SWs were taken from the interface between bone and the prosthesis, and the
BBs were likewise collected from bone in contact with the prosthesis. Each specimen was placed in a
separate sterile tube provided in the prepacked box (28). This box was used for transporting the
specimens at ambient temperature to the laboratory. Most specimens were processed within 2 h after
the revision (a delay of up to 24 h was permitted). Specimens from acute surgeries performed outside
business hours were maintained at 4°C overnight.
Specimen processing. (i) Bacteriological culture. Procedures for specimen assays, including light
microscopy, culture media, and incubations, are described in detail in Text S1 in the supplemental
material. Components of the prosthesis were immersed in sterile 1 phosphate-buffered saline (PBS)
buffer, pH 7.4, and then vortexed and sonicated, essentially as described elsewhere (24). The sonication
fluid was cultured, and the number of CFU was estimated semiquantitatively and summed over all
components without a predefined cutoff value. Likewise, BBs were submitted to vortexing and sonication
before culturing. Prosthetic SWs were vortexed in the transport medium (Copan, Italy) and the liquid
phase was cultured (Copan). All cultures were incubated for 14 days; cultures on aerobic media were
examined on days 1, 2, 4, 6, 10, and 14, and cultures on anaerobic media were examined on days 2, 4,
6, 10, and 14.
(ii) 16S rRNA sequencing. Specimens were prepared for molecular analysis by vortexing for 30 s,
and then they were stored in minimum 10% glycerol at 80°C until batch-wise processing and analysis.
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Molecular analyses were performed in a standardized manner for the five specimen types. STB, BB,
joint fluid (JF), and sonication fluid from the PCs were processed without any additional mechanical
preparation. Prosthetic SWs were vortexed in the transport medium, and the liquid phase was used for
molecular analysis.
One STB per patient was incubated with Proteinase K until it was completely dissolved. DNA was
extracted from all specimen types with MolYsis Complete5 (Molzym, Germany) according to the
manufacturer’s protocol. The other two STB were kept in reserve. A negative control (no sample included)
and a positive control (either Escherichia coli or Streptococcus pyogenes) was included for every 22
specimens. All DNA extracts were screened for the presence of bacterial DNA by amplifying the
full-length 16S rRNA with endpoint PCR (29). For all specimens that showed the presence of bacterial
DNA and for the positive and negative controls, we created 16S rRNA amplicon sequencing libraries of
the v1-v3 region. These libraries were constructed according to a modified in-house protocol (30) with
specific primers (forward primer, 5=-AGAGTTTGATCCTGGCTCAG-3=; reverse primer, 5=-ATTACCGCGGCTG
CTGG-3=; 488 bp), Taq polymerase, and 10 Key buffer (VWR, Bie & Berntsen, Søborg, Denmark) with
the MiSeq system (Illumina, USA).
The sequences were clustered into operational taxonomic units (OTU), at both 97% and 99%
similarities, to obtain separation at both the genus and species levels. We then performed sequence
alignments in the MIDAS database (30). We used the BLAST tool in the NCBI database (National Center
for Biotechnology) to search for matches to sequences that were not identified or to obtain more
detailed taxonomic information. All of the control sequences used in DNA extraction and negative PCR
assays were sequenced to enable background subtraction in sequencing (see Text S3 for details).
The molecular specimens were analyzed batch-wise after patient inclusion had been completed.
Therefore, the results did not affect the recorded diagnosis or treatment of patients.
Data analysis. A subgroup of patients had undergone a diagnostic procedure before revision. Some
received a joint puncture (n  31), others received a biopsy procedure guided by radionuclide imaging
(n  10), and others received a second surgical procedure (n  4). Diagnostic biopsy procedures and
joint punctures performed before revision were not included in our data analysis.
Cases were initially grouped according to the working diagnosis (i.e., the surgeon’s initial assessment
based on the MSIS criteria [31]). Later, they were reevaluated according to the culture report on the 5-STB
set on day 6. Infections were corroborated when 3 culture-positive STBs exhibited identical bacterial
isolates. Cases with 2 positive STBs on day 6 were further evaluated based on cultures of project
specimens. On day 14, the final assessment was made, based on the results from all specimen types.
Likelihood ratios of positive and negative results (LR and LR) were calculated for each combi-
nation of specimen type and method (32, 33). Likelihood ratios were chosen because LR and LR are
less influenced by prevalence of the target condition than other measures of accuracy. LR is the ratio
of the proportion of PJI patients with a positive result to the proportion of AF patients with a positive
result. LR is the ratio of the proportion of PJI patients with a negative result to the proportion of AF
patients with a negative result (Table 1). Calculations of LR with 95% confidence limits were carried out
at the VassarStats Website for Statistical Computation (Clinical calculator 1 at http://vassarstats.net/).
RESULTS
Study design. The prospective cohort study included patients referred due to pain
in a hip or knee arthroplasty and a possible PJI. Ethical approval was obtained from the
Regional Committee on Health Research Ethics for the Northern Denmark Region
(N-20110022). The study was conducted in the Northern Denmark Region between
December 2011 and February 2014. All residents in Denmark have unfettered access to
primary care and public hospitals. Patients waiting for an arthroplasty have a right to
seek a private clinic, but all complications are treated in public hospitals. A unique
personal identification number is used for all health records, and it provides a key that
links all health data on a given individual.
Patients with prosthesis-related problems in hips and knees were included after
obtaining informed consent. Patients with fractures and luxation in hip joints were not
eligible. The initial assessment included patient history, clinical examination, blood
biochemistry (white leukocyte count and C-reactive protein assessments were obliga-
tory), and a standard X-ray evaluated based on criteria set by the Musculoskeletal
Infection Society (MSIS) in 2011 (31).
A prepacked box with all the necessary tools, containers, and transport media was
provided for joint revisions (and another one for joint punctures) to ensure secure
individual handling of multiple specimens, as described in detail elsewhere (25, 28).
During revision surgery a set of five STBs (5-STB) was collected for culture, in compli-
ance with guidelines for PJI diagnosis in the Northern Denmark Region (1, 2). The
following project specimens were obtained in triplicate: joint fluid (JF), STB, prosthesis
swabs (SW), and bone biopsy specimens (BB). A separate container was provided for
any PCs removed. The rationale for triplicates was primarily to perfect various tech-
Best Specimens in Prosthetic Joint Infection Diagnosis Journal of Clinical Microbiology
May 2018 Volume 56 Issue 5 e01351-17 jcm.asm.org 3
 on S
eptem








niques. Special clinical conditions (e.g., osteoporosis) might have influenced the com-
pleteness of the specimen sets (missing specimens are indicated in Table S2 in the
supplemental material).
The surgeon’s diagnosis took into account any intraoperative observations and a
culture report on the 5-STB set, which was incubated for 6 days, according to standard
practice (1). According to the study protocol, clinical microbiologists evaluated any
additional isolates during extended incubation from both 5-STB and project specimens.
The surgeons had agreed to be notified only if such findings might have an impact on
the choice of antibiotic treatment.
Patient groups. A total of 156 patients were included (Fig. 1), and 111 underwent
one or more revision surgeries. Four patients were included twice, with two revisions
conducted at least 6 months apart. Of these, one patient underwent revisions of two
arthroplasties for aseptic failure (AF), defined as a prosthetic failure that was deemed
unlikely to be associated with an infection. The other three patients underwent two
revisions for PJIs; in one patient, two different joints were revised, and in two patients,
the same joint required two revisions.
One patient suspected of AF was excluded because the 5-STB set was not collected.
Thus, 114 cases were available for evaluation, including 43 cases of revision surgery for
PJI and 71 cases of revision surgery for AF (for details, see below). Revisions for PJI were
carried out within 12 weeks of the primary surgery in four cases, within 13 to 24 weeks
in four other cases, and after 24 weeks in 35 cases.
FIG 1 Flow diagram shows the patient selection and allocations. Numbers in brackets refer to patients, but numbers of cases are also indicated due to some
patients being admitted more than once.
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Among the remaining patients, 31 were diagnosed with a chronic pain condition,
and a new surgical procedure was not recommended. Ten patients were diagnosed
conclusively after an initial joint puncture.
Procedures and specimens. Table S2 provides an overview of completeness of
samples and positive results. Of the 43 cases undergoing revision surgery for PJI, 28
(65%) had a positive 5-STB set, defined as at least three positive biopsy specimens in
the set of five (Fig. 1). Of the 71 cases undergoing revision for AF, three (4%) had a
positive 5-STB set. Thus, 31 cases fulfilled the criterion of a positive 5-STB set (1), and
60 cases had entirely negative 5-STB sets.
Fourteen cases had a working diagnosis of PJI and a negative 5-STB set. Of these, six
were diagnosed with PJI based on culture-positive project specimens, three were
diagnosed with PJI based entirely on clinical findings (one was supported by 16S rRNA
sequencing), one was diagnosed with AF (all specimens were negative), three were
diagnosed with a chronic pain condition, and two had undetermined diagnoses (clinical
and diagnostic results were inconclusive).
Of the 71 cases with an initial diagnosis of AF, eight had 1 to 2 positive biopsy
specimens in the 5-STB set. Of these eight, six had entirely negative project specimens
and two had positive project specimens and thus were reallocated into the PJI
diagnosis group. One case with an entirely negative 5-STB set was grouped as unde-
termined based on MSIS criteria (31).
In total, 42 cases were finally diagnosed with PJI, based on MSIS criteria, after
diagnostic sampling. Another 66 cases were definitively diagnosed with AF, three cases
remained undetermined, and three were diagnosed with chronic pain.
16S rRNA sequencing was performed in all but two cases. Sequencing indicated
infections in 83% (33/40) of the group finally diagnosed with PJI; one of these had both
a negative 5-STB set and culture-negative project specimens (the sequencing revealed
Streptococcus spp.; data not shown). One case in the group diagnosed with AF was
positive for an infection (the sequencing revealed Finegoldia magna; data not shown).
Diagnostic performance. Accuracy of each combination of specimen type and
method (culturing or 16S rRNA sequencing) was evaluated for diagnosis of PJI. The
likelihood ratio for a positive result (LR) and the likelihood ratio for a negative result
(LR) were calculated (Table 1).
Antibiotics before surgery and 16S rRNA sequencing. Antibiotic treatment had
been administered before surgery in 24 cases. Of these, three cases were in the AF
TABLE 1 Diagnostic accuracy measured by likelihood ratios
Specimen,c culture duration (days) or
16S rRNA sequencing
No. of cases with a positive test/
no. of cases tested LRa
PJI (n  42) AF (n  66) Positive (95% CI) Negative (95% CI)
5-STB, 6 31/42 0/66 Infinityb 0.3 (0.2–0.4)
5-STB, 14 37/42 0/66 Infinity 0.1 (0.05–0.3)
JF, 6 26/39 1/57 38 (5–269) 0.3 (0.2–0.5)
JF, 14 34/39 2/56 24 (6–96) 0.1 (0.06–0.3)
PC, 6 24/37 1/60 39 (5–276) 0.4 (0.2–0.6)
PC, 14 33/37 5/60 11 (5–25) 0.1 (0.05–0.3)
SW (in situ), 6 9/32 0/59 Infinity 0.7 (0.6–0.9)
SW (in situ), 14 16/32 2/59 15 (4–60) 0.5 (0.4–0.7)
BB, 6 9/32 0/54 Infinity 0.8 (0.7–0.9)
BB, 14 13/32 1/54 22 (3–160) 0.6 (0.5–0.8)
Periprosthetic tissue, 16S rRNA sequencing 8/32 0/53 Infinity 0.8 (0.6–0.9)
Synovial fluid, 16S rRNA sequencing 25/35 1/65 46 (7–328) 0.3 (0.2–0.5)
PC, 16S rRNA sequencing 32/37 1/64 55 (8–389) 0.1 (0.06–0.3)
SW (in situ), 16S rRNA sequencing 15/34 4/52 6 (2–16) 0.6 (0.4–0.8)
BB, 16S rRNA sequencing 4/29 2/47 3 (0.6–17) 0.9 (0.8–1.0)
aPositive describes how probability of infection shifts with positive results, and negative describes how probability of infection wanes with negative results. CI,
confidence interval.
bAn incalculably large number.
cFor abbreviations of specimen types, see the text.
Best Specimens in Prosthetic Joint Infection Diagnosis Journal of Clinical Microbiology
May 2018 Volume 56 Issue 5 e01351-17 jcm.asm.org 5
 on S
eptem








group, and those cultures and 16S rRNA sequencing results were negative. The other
21 cases were in the PJI group. Of these, two showed positive results only with
sequencing (Streptococcus spp.); one was definitively diagnosed as a culture-negative
infection, and one remained undetermined. The remaining 19 PJI cases showed con-
cordant positive results from cultures and sequencing.
Infecting microorganisms. The microbial diversity of PJIs is summarized in Table 2
(for further details, see Table S2). The culture-positive PJI cases showed the following
polymicrobial infections (28%; 11/39) based on culture results: two cases of Staphylo-
coccus aureus and coagulase-negative Staphylococcus spp. (CoNS), one case of Strep-
tococcus sp. and Corynebacterium sp., one case of CoNS and Propionibacterium acnes,
one case of CoNS and Corynebacterium sp., three cases of different combinations of
CoNS species, and four cases of more than three bacterial species. The most prevalent
CoNS species were Staphylococcus epidermidis, Staphylococcus capitis, and Staphylococ-
cus lugdunensis. The four patients with early PJI (infections within 12 weeks of the
prosthesis insertion) had the following infecting microorganisms: S. aureus, polymicro-
bial (CoNS, Corynebacterium sp., and Streptococcus sp.), Enterococcus faecalis, and
Salmonella enterica serovar Dublin.
Five patients with an initial diagnosis of AF had the following infecting microorgan-
isms: CoNS (n  3), E. faecalis (n  1), and P. acnes (n  1).
With the exception of the discordant results mentioned earlier, the sequencing
results corroborated the culture results and also included additional, uncultivated
species. This finding resulted in the discovery of polymicrobial infections. We found five
polymicrobial (5/33; 15%) cases: one displayed Escherichia coli in culture plus S. aureus
sequences, one displayed E. faecalis in culture plus Finegoldia magna sequences, one
displayed several different species in culture, which were corroborated with sequenc-
ing, one displayed Staphylococcus sp. and Corynebacterium sp., and one displayed a
combination of Staphylococcus spp.; all confirmed the results obtained in cultures. Due





No. of organisms determined
by 16S rRNA sequencing
(n  33)Total Subgroup
Polymicrobial 11 5






Streptococcus spp. 4 6
Hemolytic streptococcus group Cb 2
Hemolytic streptococcus group Gb 2
Enterococcus faecalis 3 2
Escherichia coli 2
Pseudomonas aeruginosa 1
Salmonella serovar Dublin 1 1
Propionibacterium spp. 2 2
P. acnes 2
Finegoldia magna 1 1
aCulturing showed positive results in 39 cases, and sequencing showed positive results in 33 cases. Due to
the limited resolution in the 16S rRNA sequencing results, it was not possible to differentiate between
species within the genera Staphylococcus, Streptococcus, and Propionibacterium.
bThe hemolytic streptococci all were identified in culture as Streptococcus dysgalactiae.
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to our limited resolution of the v1-v3 region, the 16S rRNA sequencing could not
distinguish between Staphylococcus spp. and Streptococcus spp. at the species level.
Five specimen sets were entirely negative based on molecular methods, but some
specimens were positive with culturing methods. A semiquantitative assessment of the
sonication fluid of the PCs revealed fewer than 200 CFU/ml in four monomicrobial
cultures (E. coli, P. acnes, CoNS, and Pseudomonas aeruginosa). The fifth culture was
positive for Enterobacter sp., with 5 103 CFU/ml (data not shown). The cases with P.
aeruginosa and Enterobacter sp. were in the group of suspected PJIs; the other three
cases were suspected AFs. Two of these were reclassified as PJIs and one remained
undetermined.
Incubation period for project specimens. Within the group of cases with positive
cultures, eight did not have positive 5-STB sets on day six, but five of those eight had
positive cultures of PCs and JF within this time period (Fig. 2). An extension of the
incubation period to not less than 14 days resulted in three additional cases with
positive cultures, two in the group suspected of PJI and one in the group suspected of
AF (Fig. 3). All specimen types were represented among the late positive cultures (Fig.
2). The infecting microorganisms were S. aureus, S. epidermidis, and P. acnes. Due to the
recording method, it was only possible to distinguish between detection of culture
growth before or after day six. In no instance was it necessary to modify antibiotic
therapy due to late growth of additional bacterial species.
Contribution of positive cultures by specimen type. Positive cultures were ob-
tained in a total of 39 cases. In all except four cases, the contributions of JF and PC project
specimens could be evaluated at the same time as those of the 5-STB set (Fig. 4A). The three
specimen types were sufficient for a PJI diagnosis in this subset of patients. In 28 revisions,
all specimen types were collected (Fig. 4B). However, positive results from BB and SW
specimens did not add any information to that gained from the JF, 5-STB, and PC set results.
Of note, in one case, a positive culture was obtained only from the PC culture, and this
finding was corroborated by 16S rRNA sequencing (Table S2).
DISCUSSION
In this study, we found that results from JF, PC, and 5-STB set cultures were optimal
for the diagnosis of PJI. Conversely, novel specimen types, including the BB acquired in
close proximity to the prosthesis and the SW acquired from the prosthesis in situ, did
not contribute independently to the diagnosis. The diagnostic contribution of speci-
men types has been addressed in several previous studies but has mostly focused on
one diagnostic method or modification (20, 21, 34–38). Two recently published inter-
national guidelines for diagnosing PJI recommended the use of three to six biopsy
FIG 2 Days of incubation until growth by type of specimen (5-STB, five soft-tissue biopsy specimens; JF,
joint fluid; PC, prosthetic components; SW, swabs from the prosthesis, collected in situ; BB, bone biopsy
specimen). Incubation was planned for 14 days but occasionally was extended due to weekends and
holidays.
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specimens for culture without further specifications, and PCs were mentioned as an
adjunct to the diagnosis (8, 9). In 2014, a French group reported that four specimens,
independent of type, were the optimal number for diagnosing PJI from culture results
(34). That study acknowledged a concern about cost containment, based on the likely
rise in the number of revision surgeries, due to increasing numbers and longevity of
patients with knee and hip arthroplasties (39). The French group also concluded that
PCR-based methods had little diagnostic impact in the clinical setting (34, 35). To our
knowledge, no previous study has compared combinations of specimen types and
FIG 3 Days to positive culture for the first specimen type (black columns) and subsequent specimen types (hatched).
FIG 4 Contribution of specimen types to the diagnosis of prosthetic joint infection. (A) Thirty-five cases
were diagnosed based on positive cultures of the minimum set comprising tissue biopsy specimens
(5-STB), prosthetic components (PC), and joint fluid (JF). (B) A subgroup of 28 cases was evaluated based
on all specimen types. It is apparent that neither the bone biopsy specimen (BB) nor the prosthetic swab
(in situ) (SW) culture contributed independently to the diagnosis. *, one case diagnosis was supported by
next-generation sequencing; **, one case showed a negative result in the culture of joint fluid; ***, one
case showed negative results in the culture of prosthetic components; ****, in four cases, only one or two
specimen types contributed to the culture-positive findings.
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methods with the aim of identifying the most efficient and comprehensive (i.e.,
optimal) method for diagnosing PJI.
The heterogeneous group of patients in our study reflected clinical reality and lent
strength to the results. Our prospective study design and diagnostic algorithm were
important, because they provided a more uniform patient pathway than is otherwise
possible. Nonetheless, our approach was flexible in accommodating the individual
preferences of patients and surgeons. Both surgeons and nurses complied with the
systematic sampling procedure during the entire study period (28). This consistency
allowed direct comparisons of different specimen types and culture-based versus
molecular analyses. A limitation of our study was the lack of an independent diagnostic
reference. We accepted that the surgeons’ initial diagnosis could be modified according
to results from culturing the 5-STB set for 6 days and subsequent culturing results from
project specimens according to the MSIS criteria from 2011 (31). Consequently, six
diagnoses shifted, in one case from PJI to AF and in five cases from AF to PJI. These
modest numbers emphasized the accuracy of the surgeons’ initial judgment. Never-
theless, three cases lacked a definite diagnosis (one suspected of AF and two suspected
of PJI), and we chose to exclude them from the final assessment.
Due to these limitations, statistical evaluation of diagnostic performance must be
done cautiously. By calculating LR and LR for different combinations of specimens
and laboratory methods, we have provided an indication of the relative performance
(Table 1). It is a concern that the diagnosis of PJI was mainly driven by culture; however,
the diagnostic process was multifaceted, and the prevalence of PJI should not have a
major impact on LR and LR.
In the majority of cases, the use of antibiotics prior to sampling did not influence the
results from culturing. Only two cases were identified as positive based on 16S rRNA
sequencing alone (one had been diagnosed as PJI based on clinical indications, and one
had remained undetermined). In both cases, sequencing revealed Streptococcus sp.
infections.
Among the cases finally classified as PJI, we found a distribution of species that was
different from those found in several other studies (7, 14, 36). This difference was
probably due to the fact that 82% of our culture-positive cases were late infections
(12 weeks after primary surgery), including acute hematogenous infections and
long-term chronic infections (Table S2). It is well known that the main pathogens in
acute hematogenous infections are streptococci, enterococci, and S. aureus, and that
chronic infections are mainly caused by CoNS (40), consistent with the distribution
pattern observed in this study.
When we increased the incubation period from 6 to 14 days, we found a higher
percentage of positives in the individual specimen types, in accordance with other
studies (36, 38). However, when considering all specimens together in the incubation
period of 6 days, the JF and PC cultures alone were positive in five cases (12%; 5/42);
thus, they added significant information to the 31 cases identified with a positive 5-STB
set. In three other cases (3/42; 7%), the JF and PC cultures were positive after 6 days of
incubation. Still, three culture-negative cases were diagnosed based only on clinical
parameters. Overall, these findings indicated that an additional 19% of PJI cases (8/42)
could be confirmed with the JF, PC, and 5-STB set cultures (the optimal specimen set)
and an incubation period of not less than 14 days (26) (Fig. 4A). This result suggested
that a broad selection of specimens would permit shorter incubation times; neverthe-
less, 7% of PJIs could be missed. The number of cases in our study was too small to
draw a definite conclusion, but we observed a trend.
For infections with an early, acute onset and rapidly growing bacteria (e.g., S. aureus,
Streptococcus spp., and E. faecalis), all specimens may show positivity on day one, and
microscopic analysis of JF specimens might reveal the infecting microorganism. The
benefit of having a broad specimen collection was more apparent in difficult cases with
low-grade infections (e.g., S. epidermidis and P. acnes) and in atypical and chronic cases.
Classifying patients into those groups might facilitate allocating resources to patients
most likely to benefit from extensive sampling and diagnostic work-up.
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Comparing culturing and 16S rRNA sequencing approaches showed that sequenc-
ing only added a few extra findings. The optimization of culturing procedures, including
specimen types, culture media, and incubation times, seemed to reduce the contribu-
tion of sequencing. Sequencing is costly and time-consuming, and it requires molecular
expertise. Consequently, for economic reasons, its use may be restricted to cases where
sequencing is critical, e.g., long-term chronic cases and cases with prior antibiotic
administration. In general, the diagnostic contribution from 16S rRNA sequencing has
been restricted to liquid specimens; this constraint might be due to the higher ratio of
human to bacterial DNA in tissue biopsy specimens compared to JF and PC sonication
fluid specimens (14, 35).
Future research regarding PJI diagnosis should target the difficult-to-diagnose cases
in a prospective study. With the diagnostic specimen set concept, other promising
culture and molecular methods can be tested; for example, automatic blood culture
systems might be useful for some specimen types (20, 41, 42), and molecular methods
might be useful for selected specimens from carefully defined patients. To show real
diagnostic value, the contributions of different specimens must be evaluated in the
context of difficult-to-diagnose cases. The overall goal must be a sensitive, specific,
rapid diagnostic procedure that is readily applicable both for the surgeons and in the
clinical microbiological routine.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/JCM
.01351-17.
SUPPLEMENTAL FILE 1, PDF file, 0.2 MB.
SUPPLEMENTAL FILE 2, XLSX file, 0.1 MB.
SUPPLEMENTAL FILE 3, PDF file, 0.1 MB.
ACKNOWLEDGMENTS
Members of The PRIS Study Group listed by affiliation: Department of Orthopedic
Surgery, Aalborg University Hospital, Aalborg, Denmark (Poul Hedevang Christensen,
Mogens Brouw Jørgensen, Andreas Kappel, Mogens Berg Laursen, Poul Torben Nielsen,
Christian Pedersen, Sten Rasmussen, Jess Tvede Riis, and Ole Simonsen); Department of
Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark (Ramune Aleksyniene,
Henrik Bertelsen, Rune Fisker, Majbritt Frost, Magdalene Kubik, and Victor Iyer); Depart-
ment of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark (Iben
Ørsted); Danish Technological Institute, Biotech, Aarhus, Denmark (Peter Lüttge Jordal,
Majbritt Hauge Kyneb, and Jan Lorenzen); Department of Chemistry and Bioscience,
Aalborg University, Aalborg, Denmark (Kaare Lehmann Nielsen, Jeppe Lund Nilsen, and
Per Halkjær Nielsen); Department of Health Science and Technology, Faculty of Medi-
cine, Aalborg University (Kristian Kjær Pedersen and Lars Arendt Nielsen).
We are especially thankful to Lena Mortensen, Mette Mølvadgaard, Jane Ildal,
Susanne Bielidt, Marianne Stevensson, and Santina Castriciano for valuable assistance.
This study was conducted within the framework of the PRIS Innovation Consortium
and funded by The Danish Council for Technology and Innovation (no. 09-052174).
The sample tubes were developed in cooperation with Copan, Brescia, Italy.
Neither the Danish Council for Technology and Innovation nor Copan had any
influence on study design, collection of data, analysis and interpretation of data, writing
the manuscript, or the decision to submit the manuscript.
REFERENCES
1. Kamme C, Lindberg L. 1981. Aerobic and anaerobic bacteria in deep
infections after total hip arthroplasty: differential diagnosis between
infectious and non-infectious loosening. Clin Orthop Relat Res 154:
201–207.
2. Gundtoft PH, Overgaard S, Schønheyder HC, Møller JK, Kjærgaard-
Andersen P, Pedersen AB. 2015. The “true” incidence of surgically treated
deep prosthetic joint infection after 32,896 primary total hip arthroplas-
ties. Acta Orthop 86:326 –334. https://doi.org/10.3109/17453674.2015
.1011983.
3. Atkins B, Athanasou N, Deeks JJ, Crook DWM, Simpson H, Peto TEA,
McLardy-Smith P, Berendt AR, The Osiris Collaborative Study Group.
1998. Prospective evaluation of criteria for microbiological diagnosis of
Larsen et al. Journal of Clinical Microbiology
May 2018 Volume 56 Issue 5 e01351-17 jcm.asm.org 10
 on S
eptem








prosthesis joint infection at revision arthroplasty. J Clin Microbiol 36:
2932–2939.
4. DeHaan A, Huff T, Schabel K, Doung Y-C, Hayden J, Barnes P. 2013.
Multiple cultures and extended incubation for hip and knee arthroplasty
revision: impact on clinical care. J Arthroplasty 28:59 – 65. https://doi.org/
10.1016/j.arth.2013.03.037.
5. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna
D, Ramage G. 1998. Improved detection of infection in hip replacements.
A currently underestimated problem. J Bone Joint Surg Br 80:568 –572.
https://doi.org/10.1302/0301-620X.80B4.8473.
6. Trampuz A, Piper KE, Hanssen AD, Osmon DR, Cockerill FR, Steckelberg
JM, Patel R. 2006. Sonication of explanted prosthetic components in
bags for diagnosis of prosthetic joint infection is associated with risk of
contamination. J Clin Microbiol 44:628 – 631. https://doi.org/10.1128/
JCM.44.2.628-631.2006.
7. Trampuz A, Piper KE, Jacobson MJ, Hanssen A, Unni KK, Osmon DR, Man-
drekar J, Cockerill FR, Steckelberg JM, Geenleaf JF, Patel R. 2007. Sonication
of removed hip and knee prostheses for diagnosis of infection. N Engl J Med
357:654–663. https://doi.org/10.1056/NEJMoa061588.
8. Høiby N, Bjarnsholt T, Moser C, Bassi GL, Coenye T, Donelli G, Hall-
Stoodley L, Hola V, Imbert C, Kirketerp-Møller K, Lebeaux D, Oliver A,
Ullmann AJ, Williams C, ESCMID Study Group for Biofilms and Consulting
External Expert Werner Zimmerli. 2015. ESCMID guideline for the diag-
nosis and treatment of biofilm infections 2014. Clin Microbiol Infect
21:S1–S25. https://doi.org/10.1016/j.cmi.2014.10.024.
9. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM,
Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of America.
2013. Diagnosis and management of prosthetic joint infection: clinical
practice guidelines by the Infectious Diseases Society of America. Clin
Infect Dis 56:e1– e25. https://doi.org/10.1093/cid/cis803.
10. McDowell A, Patrick S. 2005. Evaluation of nonculture methods for the
detection of prosthetic hip biofilms. Clin Orthop Relat Res 437:74 – 82.
11. Moojen DJ, Spijkers SN, Schot CS, Nijhof MW, Vogely HC, Fleer A,
Verbout AJ, Castelein RM, Dhert WJ, Schouls LM. 2007. Identification of
orthopaedic infections using broad-range polymerase chain reaction
and reverse line blot hybridization. J Bone Joint Surg Am 89:1298 –1305.
https://doi.org/10.2106/JBJS.F.00822.
12. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR,
Gorman SP, Davis RI, Anderson N. 1999. Detection of prosthetic hip
infection at revision arthroplasty by immunofluorescence microscopy
and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol
37:3281–3290.
13. Cazanave C, Greenwood-Quaintance KE, Hanssen A, Karau MJ, Schmidt
SM, Urena EOG, Mandrekar J, Osmon DR, Lough LE, Pritt BS, Steckelberg
JM, Patel R. 2013. Rapid molecular microbiologic diagnosis of prosthetic
joint infection. J Clin Microbiol 51:2280 –2287. https://doi.org/10.1128/
JCM.00335-13.
14. Ryu SY, Greenwood-Quaintance KE, Hanssen AD, Mandrekar JN, Patel R.
2014. Low sensitivity of periprosthetic tissue PCR for prosthetic knee
infection diagnosis. Diagn Microbiol Infect Dis 79:448 – 453. https://doi
.org/10.1016/j.diagmicrobio.2014.03.021.
15. Nolte FS. 2015. Molecular microbiology, p 54 –90. In Pfaller MA,
Richter SS, Funke G, Jorgensen JH, Landry ML, Carroll KC, Warnock
DW (ed), Manual of clinical microbiology, 11th ed. ASM Press, Wash-
ington DC.
16. Wolk DM, Dunne WM. 2011. New technologies in clinical microbiology.
J Clin Microbiol 49:S62–S67. https://doi.org/10.1128/JCM.00834-11.
17. Bjerkan G, Witso E, Bergh K. 2009. Sonication is superior to scraping for
retrieval of bacteria in biofilm on titanium and steel surfaces in vitro.
Acta Orthop 80:245–250. https://doi.org/10.3109/17453670902947457.
18. Cuñé J, Soriano A, Martinez JC, Garcia S, Mensa J. 2009. A superficial
swab culture is useful for microbiologic diagnosis in acute prosthetic
joint infections. Clin Orthop Relat Res 467:531–535. https://doi.org/10
.1007/s11999-008-0553-4.
19. Esteban J, Gomez-Barrena E, Cordero J, Martin-de-Hijas NZ, Kinnari TJ,
Fernandez-Roblas R. 2008. Evaluation of quantitative analysis of cultures
from sonicated retrieved orthopedic implants in diagnosis of orthopedic
infection. J Clin Microbiol 46:488 – 492. https://doi.org/10.1128/JCM
.01762-07.
20. Font-Vizcarra L, Garcia S, Martinez-Pastor JC, Sierra JM, Soriano A. 2010.
Blood culture flasks for culturing synovial fluid in prosthetic joint infec-
tions. Clin Orthop Relat Res 468:2238 –2243. https://doi.org/10.1007/
s11999-010-1254-3.
21. Gallo J, Kolar M, Dendis M, Loveckova Y, Sauer P, Zapletalova J, Kouka-
lova D. 2008. Culture and PCR analysis of joint fluid in the diagnosis of
prosthetic joint infection. New Microbiol 31:97–104.
22. Levine BR, Evans BG. 2001. Use of blood culture vial specimens in
intraoperative detection of infection. Clin Orthop Relat Res 382:222–231.
https://doi.org/10.1097/00003086-200101000-00030.
23. Piper KE, Jacobson MJ, Cofield RH, Sperling JW, Sanchez-Sotelo J, Osmon
DR, McDowell A, Patrick S, Steckelberg JM, Mandrekar JN, Fernandez
Sampedro M, Patel R. 2009. Microbiologic diagnosis of prosthetic shoul-
der infection by use of implant sonication. J Clin Microbiol 47:
1878 –1884. https://doi.org/10.1128/JCM.01686-08.
24. Larsen LH, Lange J, Xu Y, Schønheyder HC. 2012. Optimizing culture
methods for diagnosis of prosthetic joint infections: a summary of
modifications and improvements reported since 1995. J Med Microbiol
61:309 –316. https://doi.org/10.1099/jmm.0.035303-0.
25. Larsen LH, Xu Y, Pedersen M, Schønheyder HC, Thomsen TR. 2014.
Long-term storage of clinical samples in CyMol medium for PNA-FISH
and culturing from the eSwab system. Abstr. 24th Eur Cong Clin Micro-
biol Infect Dis, abstr P0606.
26. Larsen LH, Xu Y, Khalid V, Aleksyniene R, Thomsen TR, Schønheyder HC.
2015. The optimal set for culture-based diagnosis of prosthetic joint
infections in the hip or knee. Abstr 25th Eur Cong Clin Microbiol Infect
Dis, abstr P1356.
27. Khalid V, Larsen LH, Schønheyder HC, Thomsen TR, Lorenzen J, Aleksyn-
iene R, Frost M, Rasmussen S, Study Group PRIS. 2014. New diagnostic
algorithm in evaluation of patients with prosthesis related problems in
the hip or knee. Abstr 33rd Annu Meet Eur Bone Joint Infect Soc, abstr
F005.
28. Larsen LH, Xu Y, Simonsen O, Pedersen C, Schønheyder HC, Thomsen TR,
Study Group PRIS. 2014. “All in a box” a concept for optimizing micro-
biological diagnostic sampling in prosthetic joint infections. BMC Res
Notes 7:418. https://doi.org/10.1186/1756-0500-7-418.
29. Xu Y, Rudkjøbing VB, Simonsen O, Pedersen C, Lorenzen J, Schønheyder
HC, Nielsen PH, Thomsen TR. 2012. Bacterial diversity in suspected
prosthetic joint infections: an exploratory study using 16S rRNA gene
analysis. FEMS Immunol Med Microbiol 65:291–304. https://doi.org/10
.1111/j.1574-695X.2012.00949.x.
30. McIlroy SJ, Saunders AM, Albertsen M, Nierychlo M, McIlroy B, Hansen
AA, Karst SM, Nielsen JL, Nielsen PH. 2015. MiDAS: the field guide to the
microbes of activated sludge. Database (Oxford) 2015:bav062. https://
doi.org/10.1093/database/bav062.
31. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ,
Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. 2011. New defi-
nition for periprosthetic joint infection: from the Workgroup of the
Musculoskeletal Infection Society. Clinl Orthop Relat Res 469:2992–2994.
https://doi.org/10.1007/s11999-011-2102-9.
32. Guyatt GD, Sackett DL, Haynes RB. 2006. Evaluating diagnostic test, p
273–322. In Tugwell P, Sackett DL, Guyatt GD, Haynes RB (ed), Clinical
epidemiology: how to do clinical practice research, 2nd ed. Lippincott
Williams & Wilkins, Philadelphia, PA.
33. McGee S. 2002. Simplifying likelihood ratios. J Gen Intern Med 17:
646 – 649. https://doi.org/10.1046/j.1525-1497.2002.10750.x.
34. Bémer P, Léger J, Tandé D, Plouzeau C, Valentin AS, Jolivet-Gougeon A,
Lemarié C, Kempf M, Héry-Arnaud G, Bret L, Juvin ME, Giraudeau B,
Corvec S, Burucoa C, Centre de Référence des Infections Ostéo-
Articulaires du Grand Ouest (CRIOGO) Study Team. 2016. How many
samples and how many culture media to diagnose a prosthetic joint
infection: a clinical and microbiological prospective multicenter study. J
Clin Microbiol 54:385–391. https://doi.org/10.1128/JCM.02497-15.
35. Bémer P, Plouzeau C, Tande D, Leger J, Giraudeau B, Valentin AS,
Jolivet-Gougeon A, Vincent P, Corvec S, Gibaud S, Juvin ME, Hery-
Arnaud G, Lemarie C, Kempf M, Bret L, Quentin R, Coffre C, de Pinieux
G, Bernard L, Burucoa C, Centre de Référence des Infections Ostéo-
Articulaires du Grand Ouest (CRIOGO) Study Team. 2014. Evaluation
of 16S rRNA gene PCR sensitivity and specificity for diagnosis of
prosthetic joint infection: a prospective multicenter cross-sectional
study. J Clin Microbiol 52:3583–3589. https://doi.org/10.1128/JCM
.01459-14.
36. Butler-Wu SM, Burns EM, Pottinger PS, Magaret AS, Rakeman JL, Matsen
FA, III, Cookson BT. 2011. Optimization of periprosthetic culture for
diagnosis of Propionibacterium acnes prosthetic joint infection. J Clin
Microbiol 49:2490 –2495. https://doi.org/10.1128/JCM.00450-11.
37. Hughes JG, Vetter EA, Patel R, Schleck CD, Harmsen S, Turgeant LT, Cockerill
FR. 2001. Culture with BACTEC Peds Plus/F bottle compared with conven-
Best Specimens in Prosthetic Joint Infection Diagnosis Journal of Clinical Microbiology
May 2018 Volume 56 Issue 5 e01351-17 jcm.asm.org 11
 on S
eptem








tional methods for detection of bacteria in synovial fluid. J Clin Microbiol
39:4468–4471. https://doi.org/10.1128/JCM.39.12.4468-4471.2001.
38. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. 2008.
Prolonged bacterial culture to identify late periprosthetic joint infection:
a promising strategy. Clin Infect Dis 47:1403–1409. https://doi.org/10
.1086/592973.
39. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. 2012. Economic burden
of periprosthetic joint infection in the United States. J Arthroplasty
27:61– 65.e1. https://doi.org/10.1016/j.arth.2012.02.022.
40. Stefansdottir A, Johansson D, Knutson K, Lidgren L, Robertsson O. 2009.
Microbiology of the infected knee arthroplasty: report from the Swedish
Knee Arthroplasty Register on 426 surgically revised cases. Scand J Infect
Dis 41:831– 840. https://doi.org/10.3109/00365540903186207.
41. Peel TN, Dylla BL, Hughes JG, Lynch DT, Greenwood-Quaintance KE,
Cheng AC, Mandrekar JN, Patel R. 2016. Improved diagnosis of pros-
thetic joint infection by culturing periprosthetic tissue specimens in
blood culture bottles. mBio 7:e01776-15. https://doi.org/10.1128/mBio
.01776-15.
42. Peel TN, Sedarski JA, Dylla BL, Shannon SK, Amirahmadi F, Hughes JG,
Cheng AC, Patel R. 2017. Laboratory workflow analysis of culture of
periprosthetic tissues in blood culture bottles. J Clin Microbiol 55:
2817–2826. https://doi.org/10.1128/JCM.00652-17.
Larsen et al. Journal of Clinical Microbiology
May 2018 Volume 56 Issue 5 e01351-17 jcm.asm.org 12
 on S
eptem
ber 10, 2018 by guest
http://jcm
.asm
.org/
D
ow
nloaded from
 
